Multidrug resistance protein (MRP) expression in retinoblastoma correlates with the rare failure of chemotherapy despite cyclosporine for reversal of P-glycoprotein

Cancer Research

Volumn 57, Issue 12, 1997, Pages 2325-2330

  Chan, Helen S L ^a,b   Lu, Ying ^b   Grogan, Thomas M ^e   Haddad, George ^a,b   Hipfner, David R ^d   Cole, Susan P C ^d   Deeley, Roger G ^d   Ling, Victor ^c   Gallie, Brenda L ^b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d QUEEN S UNIVERSITY   (Canada)

^e UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DOXORUBICIN; GLYCOPROTEIN P; HYDROCORTISONE; HYDROXYUREA; IFOSFAMIDE; METHOTREXATE; METHYLPREDNISOLONE; PROCARBAZINE; TENIPOSIDE; VINCRISTINE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CHILD; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENUCLEATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPEROXIDASE STAINING; INFANT; INTRATHECAL DRUG ADMINISTRATION; MULTIDRUG RESISTANCE; NEWBORN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINOBLASTOMA; TREATMENT FAILURE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ATP-BINDING CASSETTE TRANSPORTERS; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CYCLOSPORINE; DRUG RESISTANCE, NEOPLASM; EYE ENUCLEATION; EYE NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INFANT, NEWBORN; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; P-GLYCOPROTEIN; RETINOBLASTOMA;

EID: 0030958259     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Georges, E., Bradley, G., Gariepy, J., and Ling, V. Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies. Proc. Natl. Acad. Sci. USA, 87: 152-156, 1990.
2. r 190,000 multidrug resistance protein, MRP, with monoclonal antibodies. Cancer Res., 54: 5788-5792, 1994.
3. Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M., and Deeley, R. G. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science (Washington DC), 258: 1650-1654, 1992.
4. Grant, C. E., Valdimarsson, G., Hipfner, D. R., Almquist., K. C., Cole, S. P., and Deeley, R. G. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res., 54: 357-361, 1994.
5. Loe, D. W., Deeley, R. G., and Cole, S. P. C. Biology of the multidrug resistance-associated protein, MRP. Eur. J. Cancer, 32A: 945-957, 1996.
6. Chan, H. S. L., Thorner, P. S., Haddad, G., and Ling, V. Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood. J. Clin. Oncol., 8: 689-704, 1990.
7. Chan, H. S. L., Haddad, G., Thorner, P. S., DeBoer, G., Lin, Y. P., Ondrusek, N., Yeger, H., and Ling, V. P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. N. Engl. J. Med., 325: 1608-1614, 1991.
8. List, A. F., Spier, C., Greer, J., Wolff, S., Hutter, J., Dorr, R., Salmon, S., Futscher, B., Baier, M., and Dalton, W. Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia. J. Clin. Oncol., 11: 1652-1660, 1993.
9. Bartlett, N. L., Lum, B. L., Fisher, G. A., Brophy, N. A., Ehsan, M. N., Halsey, J., and Sikic, B. I. Phase I trial of doxorubicin with cyclosporine as a modulator of multidrug resistance. J. Clin. Oncol., 12: 835-842, 1994.
10. Wilson, W. H., Bates, S. E., Fojo, A., Bryant, G., Zhan, Z., Regis, J., Wittes, R. E., Jaffe, E. S., Steinberg, S. M., Herdt, J., and Chabner, B. A. Controlled trial of dexverapamil, a modulator of multidrug resistance, in lymphomas refractory to EPOCH chemotherapy. J. Clin. Oncol., 13: 1995-2004, 1995.
11. Kuss, B. J., Deeley, R. G., Cole, S. P. C., Willman, C. L., Kopecky, K. J., Wolman, S. R., Eyre, H. J., Lane, S. A., Nancarrow, J. K., Whitmore, S. A., and Callen, D. F. Deletion of gene for multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16: prognostic implications. Lancet, 343: 1531-1534, 1994.
12. Eng, C., Li, F. P., Abramson, D. H., Ellsworth, R. M., Wong, F. L., Goldman, M. B., Seddon, J., Tarbell, N., and Boice, J. D., Jr. Mortality from second tumors among long-term survivors of retinoblastoma. J. Natl. Cancer Inst., 85: 1121-1128, 1993.
13. Chan, H. S. L., Thorner, P. S., Haddad, G., and Gallie, B. L. Multidrug-resistant phenotype in retinoblastoma correlates with P-glycoprotein expression. Ophthalmology, 98: 1425-1431, 1991.
14. Chan, H. S. L., DeBoer, G., Thiessen, J. J., Budning, A., Kingston, J. E., O'Brien, J. M., Koren, G., Giesbrecht, E., Haddad, G., Verjee, Z., Hungerford, J. L., Ling, V., and Gallie, B. L. Combining cyclosporin with chemotherapy controls intraocular retinoblastoma without requiring radiation. Clin. Cancer Res., 2: 1499-1508, 1996.
15. Gallie, B. L., Budning, A., DeBoer, G., Thiessen, J. J., Koren, G., Verjee, Z., Ling, V., and Chan, H. S. L. Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiation. Arch. Ophthalmol., 114: 1321-1328, 1996.
16. Abramson, D. H., Ellsworth, R. M., Tretter, P., Adams, K., and Kitchin, F. D. Simultaneous bilateral radiation for advanced bilateral retinoblastoma. Arch. Ophthalmol., 99: 1763-1766, 1981.
17. Murphree, A. L., Villablanca, J. G., Deegan, W. F., Sato, J. K., Malogolowkin, M., Fisher, A., Parker, R., Reed, E., and Gomer, C. J. Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch. Ophthalmol., 114: 1348-1356, 1996.
18. Kingston, J. E., Hungerford, J. L., Madreperla, S. A., and Plowman, P. N. Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma. Arch. Ophthalmol., 114: 1339-1343, 1996.
19. Chan, H. S. L., Grogan, T. M., Haddad, G., Hipfner, D. R., Deeley, R. G., and Cole, S. P. C. Standardization of a single-cell assay for sensitive detection of multidrug resistance protein (MRP) expression in normal and malignant cells in archival clinical samples. J. Lab. Clin. Med., in press, 1997.
20. Bradley, G., Naik, M., and Ling, V. P-glycoprotein expression in multidrug-resistant human ovarian carcinoma cell lines. Cancer Res., 49: 2790-2796, 1989.
21. Beck, W. T., Grogan, T. M., Willman, C., Cordon-Cardo, C., Parham, D. M., Kuttesch, J. F., Andreeff, M., Bates, S. E., Berard, C. W., Boyett, J. M., Brophy, N. A., Broxterman, H. J., Chan, H. S. L., Dalton, W. S., Dietel, M., Fojo, A. T., Gascoyne, R. D., Head, D., Houghton, P. J., Srivastava, D. K., Lehnert, M., Leith, C. P., Paietta, E., Pavelic, Z., Rimsza, L., Roninson, I. B., Sikic, B. I., Twentyman, P. R., Warnke, R., and Weinstein, R. Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations. Cancer Res., 56: 3010-3020, 1996.
22. Flens, M. J., Zaman, G. J., van der Valk, P., Izquierdo, M. A., Schroeijers, A. B., Scheffer, G. L., van der Groep, P., de Haas, M., Meijer, C. J., and Scheper, R. J. Tissue distribution of the multidrug resistance protein. Am. J. Pathol., 148: 1237-1247, 1996.
23. Norris, M. D., Bordow, S. B., Marshall, G. M., Haber, P. S., Cohn, S. L., and Haber, M. Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma. N. Engl. J. Med., 334: 231-238, 1996.
24. Cole, S. P. C., Sparks, K. E., Fraser, K., Loe, D. W., Grant, C. E., Wilson, G. M., and Deeley, R. G. Pharmacological characterization of multidrug-resistant MRP-transtected human tumor cells. Cancer Res., 54: 5902-5910, 1994.
25. Slater, L. M., Cho, J., and Wetzel, M. Cyclosporin A potentiation of VP-16: production of long-term survival in murine acute lymphatic leukemia. Cancer Chemother. Pharmacol., 31: 53-56, 1992.
26. Kashani-Sabet, M., Wang, W., and Scanlon, K. J. Cyclosporin A suppresses cisplatininduced c-fos gene expression in ovarian carcinoma cells. J. Biol. Chem., 265: 11285-11288, 1990.